Actively Recruiting
International Observational Study on Healthcare and Quality of Life in Hidradenitis Suppurativa Patients
Led by Julia Tatjana Maul · Updated on 2026-09-28
9600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting the Global Healthcare Study on Hidradenitis Suppurativa GHSHS, an international observational study led by the University of Zurich. The study aims to understand healthcare access, treatment patterns, disease severity, and quality of life in patients with hidradenitis suppurativa by collecting standardized clinical data. This research seeks to identify differences in healthcare delivery and outcomes across various healthcare systems. The study uses both retrospective and prospective data collection from routine clinical care and medical records starting from January 2020 until the study ends. There are no investigational treatments instead, the study observes patients during their usual care. Clinical data includes disease severity assessments and quality of life evaluations over time. Participants will have data collected from their routine medical visits at baseline and follow-up every 6 to 12 months for up to 5 years. Researchers will measure disease severity using tools like the International Hidradenitis Suppurativa Severity Score System IHS4 and other scoring systems, along with patient-reported pain and quality of life assessments. The study monitors participants health status over a long period without altering their care.
CONDITIONS
Brief Title
Global Healthcare Study on Hidradenitis Suppurativa
Research Team
J
Julia-Tatjana Maul, Prof. Dr. med.
J
Johannes Didaskalu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here